J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hope, H. R.
Right arrow Articles by Connolly, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hope, H. R.
Right arrow Articles by Connolly, D. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 41, 1604-1614, October 2000
Copyright © 2000 by Lipid Research, Inc.


Original Article

Inhibition of cholesteryl ester transfer protein by substituted dithiobisnicotinic acid dimethyl ester: involvement of a critical cysteine

Heidi Rath Hopea, Deborah Heuvelmane, Kevin Duffinb, Christine Smitha, Jeffery Zablockic, Roger Schillingd, Shridhar Hegdec, Len Leec, Bryan Witherbeee, Mark Baganoffa, Can Brucef, Alan R. Tallf, Elaine Krule, Kevin Glenne, and Daniel T. Connollye
a Biochemistry and Molecular Biology, Pharmacia, St. Louis, MO, 63198
b Analytical Sciences, Pharmacia, St. Louis, MO, 63198
c Chemical Sciences, Pharmacia, St. Louis, MO, 63198
d High Throughput Screening, Pharmacia, St. Louis, MO, 63198
e Cardiovascular Research, Pharmacia, St. Louis, MO, 63198
f Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY 10032

Correspondence to: Heidi Rath Hope

SC-71952, a substituted analog of dithiobisnicotinic acid dimethyl ester, was identified as a potent inhibitor of cholesteryl ester transfer protein (CETP). When tested in an in vitro assay, the concentration of SC-71952 required for half-maximal inhibition was 1 µM. The potency of SC-71952 was enhanced 200-fold by preincubation of the inhibitor with CETP, and was decreased 50-fold by treatment with dithiothreitol. Analogs of SC-71952 that did not contain a disulfide linkage were less potent, did not display time dependency, and were not affected by dithiothreitol treatment. Kinetic and biochemical characterization of the inhibitory process of CETP by SC-71952 suggested that the inhibitor initially binds rapidly and reversibly to a hydrophobic site on CETP. With time, the bound inhibitor irreversibly inactivates CETP, presumably by reacting with one of the free cysteines of CETP. Liquid chromatography/mass spectroscopy (LC/MS) analyses of tryptic digests of untreated or SC-71952-inactivated CETP was used to identify which cysteine(s) were potentially involved in the time-dependent, irreversible component of inactivation by the inhibitor. One disulfide bond, Cys143;–Cys184, was unaffected by treatment with the inhibitor. Inactivation of CETP by SC-71952 correlated with a progressive decrease in the abundance of free Cys-13 and Cys-333. Conversion of Cys-13 to alanine had no effect on the rapid reversible component of inactivation by SC-71952. However, it abolished the time-dependent enhancement in potency seen with the inhibitor when using wild-type CETP.

These data indicate that Cys-13 is critical for the irreversible inactivation of CETP by SC-71952 and provides support for the structural model that places Cys-13 near the neutral lipid-binding site of CETP.—H. R. Hope, D. Heuvelman, K. Duffin, C. Smith, J. Zablocki, R. Schilling, S. Hegde, L. Lee, B. Witherbee, M. Baganoff, C. Bruce, A. R. Tall, E. Krul, K. Glenn, and D. T. Connolly. Inhibition of cholesteryl ester transfer protein by substituted dithiobisnicotinic acid dimethyl ester: involvement of a critical cysteine. J. Lipid Res. 2000. 41: 1604;–1614.

Supplementary key words: disulfide mapping, LC/MS, HDL, LDL


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. W. Clark, R. B. Ruggeri, D. Cunningham, and M. J. Bamberger
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action
J. Lipid Res., March 1, 2006; 47(3): 537 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Dumont, T. Gautier, J.-P. P. de Barros, H. Laplanche, D. Blache, P. Ducoroy, J. Fruchart, J.-C. Fruchart, P. Gambert, D. Masson, et al.
Molecular Mechanism of the Blockade of Plasma Cholesteryl Ester Transfer Protein by Its Physiological Inhibitor Apolipoprotein CI
J. Biol. Chem., November 11, 2005; 280(45): 38108 - 38116.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.